CN113855930A - A skin caring injection method for removing wrinkle and regenerating collagen by hand injection - Google Patents
A skin caring injection method for removing wrinkle and regenerating collagen by hand injection Download PDFInfo
- Publication number
- CN113855930A CN113855930A CN202111238137.7A CN202111238137A CN113855930A CN 113855930 A CN113855930 A CN 113855930A CN 202111238137 A CN202111238137 A CN 202111238137A CN 113855930 A CN113855930 A CN 113855930A
- Authority
- CN
- China
- Prior art keywords
- point
- area
- carrier
- hand
- position end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002347 injection Methods 0.000 title claims abstract description 87
- 239000007924 injection Substances 0.000 title claims abstract description 87
- 238000000034 method Methods 0.000 title claims abstract description 45
- 230000037303 wrinkles Effects 0.000 title claims abstract description 35
- 102000008186 Collagen Human genes 0.000 title claims abstract description 30
- 108010035532 Collagen Proteins 0.000 title claims abstract description 30
- 229920001436 collagen Polymers 0.000 title claims abstract description 30
- 230000001172 regenerating effect Effects 0.000 title description 7
- 239000000725 suspension Substances 0.000 claims abstract description 71
- 239000002131 composite material Substances 0.000 claims abstract description 56
- 229920006237 degradable polymer Polymers 0.000 claims abstract description 40
- 230000000994 depressogenic effect Effects 0.000 claims abstract description 30
- 230000003796 beauty Effects 0.000 claims abstract description 23
- 230000008929 regeneration Effects 0.000 claims abstract description 16
- 238000011069 regeneration method Methods 0.000 claims abstract description 16
- 238000004140 cleaning Methods 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 230000000249 desinfective effect Effects 0.000 claims abstract description 6
- 238000005192 partition Methods 0.000 claims abstract description 6
- 238000000638 solvent extraction Methods 0.000 claims abstract description 6
- 229920000642 polymer Polymers 0.000 claims description 21
- 210000001519 tissue Anatomy 0.000 claims description 20
- 239000002537 cosmetic Substances 0.000 claims description 14
- 210000000988 bone and bone Anatomy 0.000 claims description 13
- 239000000945 filler Substances 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 238000007920 subcutaneous administration Methods 0.000 claims description 7
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 6
- 230000002980 postoperative effect Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 206010042674 Swelling Diseases 0.000 claims description 3
- 229940006091 aloe polysaccharide Drugs 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- 239000002612 dispersion medium Substances 0.000 claims description 3
- 229960003276 erythromycin Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 229960001855 mannitol Drugs 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 238000013329 compounding Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 230000002045 lasting effect Effects 0.000 abstract description 3
- 230000008093 supporting effect Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 19
- 210000003195 fascia Anatomy 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 201000010251 cutis laxa Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 210000004553 finger phalanx Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a beauty injection method for wrinkle removal and collagen regeneration by hand injection, which comprises the following steps: cleaning and disinfecting the contour of the back of the hand; preparing a composite high-molecular degradable polymer suspension carrier; injecting the beauty injection liquid into the axial line point position of the oblique edge position of the contour between depressed fingers on the back of the hand; partitioning the hand back contour by using a principle of 5-dimensional point distance and V point axis inclined edge; injecting a composite high-molecular degradable polymer suspension carrier to the partition axis point. Has the advantages that: the hand skin care liquid is injected into a suspension carrier in a short period by the principle of 5-dimensional point distance and V-point axis inclined edge to achieve the lasting supporting effect of contour skin between sunken fingers on the back of a hand, has the characteristics of stable physical and chemical properties, strong inertia and better biocompatibility, can effectively improve the loose and wrinkles of the hand skin, can remove the wrinkles more thoroughly, has a more natural beautifying effect, and realizes the integral youthfulness of the hand.
Description
Technical Field
The invention relates to the field of micro-plastic cosmetology, in particular to a cosmetic injection method for removing wrinkles and regenerating collagen by hand injection.
Background
With the age, people are often troubled by the problems of wrinkles, loose skin, prominent and hyperplastic bone joints and the like, and when the collagen fibers and the elastic fibers of the dermis lose elasticity, the phenomena of hand depression and wrinkles are formed.
At present, the traditional operation mode of minimally invasive wrinkle removal from small hand incisions is selected for most of cosmetic methods adopted by plastic mechanisms, and the traditional operation mode is that a specially-made wrinkle removal instrument is used for correctly separating the deep surface of a skin, muscle and periosteum through a tiny incision in the scalp, so that the wrinkle removal effect is achieved. The results of traditional surgical procedures result from long recovery period after surgery, bleeding, hematoma and scar tissue. The fear of postoperative pain and the influence of postoperative recovery period on life and work are hindered, and people need a beautifying technique with small wound, quick recovery and long effective period. Nowadays, the key to injecting cosmetics is "injection material" and "cosmetic injection method". By adopting the beauty treatment method of injecting substances to the local part of the human body, the safety therapy is proved by clinic, the recovery time of the treatment area is faster, the work and the life of beauty lovers are not influenced, and the beauty lovers can be provided with a new beauty treatment method.
Therefore, the hand sunken wrinkle area is filled up by the cosmetic injection method through the suspension carrier, the wrinkles and loose skin are tightened and promoted to return to the original position of the tissue, the dynamic balance of the hand tissue is adjusted, and the youth of the hand contour is recovered. And the tissue filler is metabolized into neutral and nontoxic water and carbon dioxide in human body. Therefore, the invention provides a novel injection method with good beauty, and the compound high molecular degradable polymer suspension carrier with good biocompatibility is milder than other filling injection, which has very important significance for injection beauty.
An effective solution to the problems in the related art has not been proposed yet.
Disclosure of Invention
The present invention provides a skin care injection method for wrinkle removal and collagen regeneration by hand injection, which solves the above technical problems of the prior art.
Therefore, the invention adopts the following specific technical scheme:
a beauty injection method for removing wrinkles and regenerating collagen by adopting hand injection comprises the following steps:
s1, cleaning and disinfecting the back contour of the hand;
s2, preparing a composite high-molecular degradable polymer suspension carrier;
s3, injecting the beauty injection liquid into the axial line point of the oblique edge of the contour between the depressed fingers on the back of the hand;
s4, partitioning the hand back contour by using the principle of 5-dimensional point distance and position and V point axis inclined edge;
s5, injecting the composite high molecular degradable polymer suspension carrier to the partition axis point.
Further, the cleaning and disinfecting work of the back contour of the hand comprises the following steps:
s101, cleaning the contour skin of the back of a hand by using clear water;
s102, after cleaning, performing sterile disinfection on the left and right sides of the back of the hand;
s103, sterilizing the injection part by 70 percent medical sterile alcohol solution before injection.
Further, the composite high-molecular degradable polymer suspension carrier comprises a polymeric tissue filler and a synergist;
wherein the polymeric tissue filler comprises sodium hyaluronate and poly-L-lactic acid;
the synergist comprises sodium hydroxymethyl cellulose, mannitol, aloe polysaccharide, glycerol, amino acids, peptide, vitamins and growth factor.
Further, the preparation method for preparing the composite type high molecular degradable polymer suspension carrier adopts dispersion medium liquid to uniformly mix the polymeric tissue filler and the synergist for formula ratio, and the composite type high molecular degradable polymer suspension carrier is prepared by compounding.
Further, the step of partitioning the hand back contour by using the principle of 5-dimensional point distance and V point axis inclined edge comprises the following steps: the back contour of the hand is divided into a left-right symmetrical area A, an area B, an area C, an area D, an area E, an area F, an area G, an area H, an area I and an area J.
Further, injecting the composite high molecular degradable polymer suspension carrier to the partition axis point comprises respectively injecting the composite high molecular degradable polymer suspension carrier to the point position of the contour between the depressed fingers on the back of the hand and the oblique edge position of the contour between the depressed fingers on the back of the hand by utilizing the principle of 5-dimensional point distance position and V-point axial oblique edge, and completing the injection of the composite high molecular degradable polymer suspension carrier by inserting a needle head at a slant angle of 10-15 degrees by utilizing the clearance of the bones of the fingers, the actual point position and the oblique edge position of the contour between the depressed fingers on the right hand and the actual point position and the oblique edge position of the contour between the depressed fingers on the left hand, wherein the needle head uses a blunt needle mode, and the needle is pushed to slowly administer the drug according to the condition.
Further, the injection of the composite high molecular degradable polymer suspension carrier is completed by respectively injecting the composite high molecular degradable polymer suspension carrier into the point position of the contour between depressed fingers on the back of the hand by utilizing the principle of 5-dimensional point distance position, and inserting a needle head into the actual point position of the contour on the back of the right hand by utilizing the gap of the bones of the fingers and obliquely cutting 10-15 angles, and the method comprises the following steps:
s501, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area B in a preset direction;
s502, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area C in a preset direction;
s503, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area D in a preset direction;
s504, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area E in a preset direction.
The method comprises the following steps of respectively injecting the composite high molecular degradable polymer suspension carrier into the dot orientation positions of the contour between the depressed fingers on the back of the hand by utilizing the principle of 5-dimensional dot distance positions, and completing the injection of the composite high molecular degradable polymer suspension carrier by inserting a needle head into the actual dot orientation positions of the contour between the depressed fingers on the back of the left hand in a manner of beveling by 10-15 angles by utilizing the gaps of the bones of the fingers:
s505, taking a needle inserting point at the position end along the F area, and uniformly injecting 0.5ml of carrier in the preset direction to the G area;
s506, a needle inserting point is arranged at the position end along the F area, and 0.5ml of carrier is uniformly injected into the H area in a preset direction;
s507, needle inserting points are arranged at the position end along the F area, and 0.5ml of carriers are uniformly injected into the I area in a preset direction;
s508, the needle inserting point is arranged at the position end along the F area, and 0.5ml of carrier is evenly injected to the J area in the preset direction.
Further, the injection of the composite polymer degradable suspension carrier is completed by injecting the composite polymer degradable suspension carrier into the oblique edge position of the contour between the depressed fingers on the back of the hand and inserting the needle head into the oblique edge position of the contour on the back of the right hand at a bevel angle of 10-15 degrees by utilizing the principle of the oblique edge of the V-point shaft, which comprises the following steps:
s509, a needle inserting point is arranged at the position end along the B area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s510, a needle inserting point is arranged at the position end along the area B, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s511, a needle inserting point is arranged at the position end along the C area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s512, a needle inserting point is arranged at the position end along the area C, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s513, a needle inserting point is arranged at the position end along the D area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s514, a needle inserting point is arranged at the position end along the D area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s515, a needle point is arranged at the position end along the E area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s516, a needle inserting point is arranged at the position end along the E area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards.
The method comprises the following steps of respectively injecting a composite high molecular degradable polymer suspension carrier into the oblique edge position of the contour between the depressed fingers on the back of the hand by utilizing the principle of the oblique edge of the V-point shaft, and inserting a needle head into the oblique edge position of the contour on the back of the left hand at a beveling angle of 10-15 degrees by utilizing the clearance of the bones of the fingers to complete the injection of the composite high molecular degradable polymer suspension carrier:
s517, a needle inserting point is arranged at the position end along the G area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s518, a needle inserting point is arranged at the position end along the G area, and 0.1ml-0.3ml of carrier is uniformly injected into the 2 points along the position end of the 2 points upwards;
s519, a needle inserting point is arranged at the position end along the H area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point upwards along the position end of the 1 point;
s520, a needle inserting point is arranged at the position end along the H area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s521, a needle inserting point is arranged at the position end along the area I, and 0.1ml-0.3ml of carrier is uniformly injected to the point 1 upwards along the position end of the point 1;
s522, a needle inserting point is arranged at the position end along the I area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s523, a needle inserting point is arranged at the position end along the J area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
and S524, a needle inserting point is arranged at the position end along the J area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards.
Furthermore, the injection composite type high molecular degradable polymer suspension carrier exists in the subcutaneous fascia tissue of human skin in the form of suspension medium.
Furthermore, after the injection of the composite type high molecular degradable polymer suspension carrier is finished, the shaping is adjusted according to the condition, the massage can be finished when the massage is smooth, the needle hole is not sutured, and the erythromycin ointment is coated outside, so that the postoperative swelling is reduced.
The invention has the beneficial effects that:
1. the invention provides a beauty injection method for removing wrinkles and regenerating collagen by hand injection, which is characterized in that 5-dimensional point distance and V-point axis inclined edge are supplemented, the beauty injection method is technically and safely injected into subcutaneous fascia tissue of the contour between sunken fingers on the back of a hand by a medical practitioner, each point is uniformly provided with a suspension carrier, the suspension carrier is injected into the subcutaneous fascia tissue through a needle to improve skin looseness and wrinkles, stimulate collagen fiber proliferation, fill and support the contour between the sunken fingers on the back of the hand, and the skin on the contour between the sunken fingers on the back of the hand can be puffed without more wound openings, so that local collagen loss can be improved, the work and life of beauty lovers cannot be influenced, and the beauty injection method can quickly improve the characteristics of hand collapse and local skin aging.
2. The invention provides a solution that the deep maintenance and nursing of the contour skin between sunken fingers on the back of a hand are difficult to realize in the prior art. The technology proves that the beauty injection method for removing wrinkles by hand injection and regenerating collagen can achieve the lasting supporting effect of contour skin between sunken fingers on the back of a hand in a short period by injecting a suspension carrier by the principle of 5-dimensional point distance and V-point axis inclined edge, has the characteristics of stable physicochemical property, strong inertia and good biocompatibility, and has good effect after injection, and the technology proves that the hand fullness is effectively realized. Therefore, the invention provides a novel injection method for beautifying, which is matched with a composite high-molecular degradable polymer suspension carrier with good biocompatibility, is milder compared with other filling injection solutions, and the collagen hyperplasia of the hand contour skin can be maintained for about 1 year and half to 2 years, thereby having very important significance for injection beautifying.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings needed in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings without creative efforts.
FIG. 1 is a schematic flow chart of a cosmetic injection method for wrinkle removal and collagen regeneration using hand injection according to an embodiment of the present invention;
FIG. 2 is a flowchart of a method for skin care injection using hand injection for wrinkle removal and collagen regeneration, according to an embodiment of the present invention;
fig. 3 is a second flowchart of a cosmetic injection method for wrinkle removal and collagen regeneration by hand injection according to an embodiment of the present invention.
Detailed Description
For further explanation of the various embodiments, the drawings which form a part of the disclosure and which are incorporated in and constitute a part of this specification, illustrate embodiments and, together with the description, serve to explain the principles of operation of the embodiments, and to enable others of ordinary skill in the art to understand the various embodiments and advantages of the invention, and, by reference to these figures, reference is made to the accompanying drawings, which are not to scale and wherein like reference numerals generally refer to like elements.
According to the embodiment of the invention, a beauty injection method for wrinkle removal and collagen regeneration by hand injection is provided.
Referring now to the drawings and the detailed description, the present invention will be further described, as shown in fig. 1, in accordance with an embodiment of the present invention, a cosmetic injection method for wrinkle removal and collagen regeneration by hand injection, the method comprising the steps of:
s1, cleaning and disinfecting the back contour of the hand;
s2, preparing a composite high-molecular degradable polymer suspension carrier;
s3, injecting the beauty injection liquid into the axial line point of the oblique edge of the contour between the depressed fingers on the back of the hand;
s4, partitioning the hand back contour by using the principle of 5-dimensional point distance and position and V point axis inclined edge;
s5, injecting the composite high molecular degradable polymer suspension carrier to the partition axis point.
In one embodiment, said performing the cleaning and sanitizing of the back hand contours comprises the steps of:
s101, cleaning the contour skin of the back of a hand by using clear water;
s102, after cleaning, performing sterile disinfection on the left and right sides of the back of the hand;
s103, sterilizing the injection part by 70 percent medical sterile alcohol solution before injection.
In one embodiment of the present invention,
the composite high molecular degradable polymer suspension carrier comprises a polymeric tissue filler and a synergist;
wherein the polymeric tissue filler comprises sodium hyaluronate and poly-L-lactic acid;
the synergist comprises sodium hydroxymethyl cellulose, mannitol, aloe polysaccharide, glycerol, amino acids, peptide, vitamins and growth factor.
In one embodiment, the preparation method for preparing the composite polymer degradable polymer suspension carrier adopts a dispersion medium liquid (physiological saline) to uniformly mix the polymeric tissue filler and the synergist for formula ratio, and the composite polymer degradable polymer suspension carrier is prepared.
As shown in fig. 2 and 3, in one embodiment, the partitioning the hand back contour by using the principle of 5-dimensional point distance and V-point axis bevel edge comprises the following steps: the back contour of the hand is divided into a left-right symmetrical area A, an area B, an area C, an area D, an area E, an area F, an area G, an area H, an area I and an area J.
In one embodiment, the injecting the composite polymer degradable suspension carrier into the bisecting axis point comprises injecting the composite polymer degradable suspension carrier into the point position of the hand back depressed finger space contour and the point position of the hand back depressed finger space contour diagonal edge respectively by using the principle of 5-dimensional point distance position and V-point axis diagonal edge, and completing the injection of the composite polymer degradable suspension carrier by inserting a needle head at a bevel angle of 10-15 degrees by using the clearance of the finger bones, the actual point position and the diagonal edge position of the right hand back contour and the actual point position and the diagonal edge position of the left hand back depressed finger space contour, wherein the needle head uses a blunt needle mode and is pushed to slowly administer the drug as appropriate.
Specifically, the principle of 5-dimensional point distance and V-point axis inclined edge is adopted, depression and wrinkles of the contour between fingers of the back of the hand are improved, fat and skin of the contour of the back of the hand are more water-lubricated and smooth, and the contour shape of the back of the hand is integrally enabled to achieve the optimal locking smooth effect.
As shown in fig. 2 and fig. 3, in an embodiment, the injecting of the composite polymer suspension carrier is accomplished by injecting the composite polymer suspension carrier into the point positions of the contour between the depressed fingers of the back of the hand respectively by using the principle of 5-dimensional point spacing, and inserting the needle into the actual point positions of the contour of the back of the right hand at an oblique angle of 10-15 degrees by using the gaps between the bones of the fingers, and the method comprises the following steps:
s501, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area B in a preset direction;
s502, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area C in a preset direction;
s503, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area D in a preset direction;
s504, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area E in a preset direction.
The method comprises the following steps of respectively injecting the composite high molecular degradable polymer suspension carrier into the dot orientation positions of the contour between the depressed fingers on the back of the hand by utilizing the principle of 5-dimensional dot distance positions, and completing the injection of the composite high molecular degradable polymer suspension carrier by inserting a needle head into the actual dot orientation positions of the contour between the depressed fingers on the back of the left hand in a manner of beveling by 10-15 angles by utilizing the gaps of the bones of the fingers:
s505, taking a needle inserting point at the position end along the F area, and uniformly injecting 0.5ml of carrier in the preset direction to the G area;
s506, a needle inserting point is arranged at the position end along the F area, and 0.5ml of carrier is uniformly injected into the H area in a preset direction;
s507, needle inserting points are arranged at the position end along the F area, and 0.5ml of carriers are uniformly injected into the I area in a preset direction;
s508, the needle inserting point is arranged at the position end along the F area, and 0.5ml of carrier is evenly injected to the J area in the preset direction.
As shown in fig. 2 and fig. 3, in an embodiment, the injecting of the composite polymer degradable suspension carrier by injecting the composite polymer degradable suspension carrier into the oblique edge position of the contour between the depressed fingers on the back of the hand and inserting the needle into the oblique edge position of the contour on the back of the right hand at an angle of 10-15 degrees by using the gap between the bones of the fingers comprises the following steps:
s509, a needle inserting point is arranged at the position end along the B area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s510, a needle inserting point is arranged at the position end along the area B, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s511, a needle inserting point is arranged at the position end along the C area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s512, a needle inserting point is arranged at the position end along the area C, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s513, a needle inserting point is arranged at the position end along the D area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s514, a needle inserting point is arranged at the position end along the D area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s515, a needle point is arranged at the position end along the E area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s516, a needle inserting point is arranged at the position end along the E area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards.
The method comprises the following steps of respectively injecting a composite high molecular degradable polymer suspension carrier into the oblique edge position of the contour between the depressed fingers on the back of the hand by utilizing the principle of the oblique edge of the V-point shaft, and inserting a needle head into the oblique edge position of the contour on the back of the left hand at a beveling angle of 10-15 degrees by utilizing the clearance of the bones of the fingers to complete the injection of the composite high molecular degradable polymer suspension carrier:
s517, a needle inserting point is arranged at the position end along the G area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s518, a needle inserting point is arranged at the position end along the G area, and 0.1ml-0.3ml of carrier is uniformly injected into the 2 points along the position end of the 2 points upwards;
s519, a needle inserting point is arranged at the position end along the H area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point upwards along the position end of the 1 point;
s520, a needle inserting point is arranged at the position end along the H area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s521, a needle inserting point is arranged at the position end along the area I, and 0.1ml-0.3ml of carrier is uniformly injected to the point 1 upwards along the position end of the point 1;
s522, a needle inserting point is arranged at the position end along the I area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s523, a needle inserting point is arranged at the position end along the J area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
and S524, a needle inserting point is arranged at the position end along the J area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards.
Specifically, using the principle of the V-point axis bevel edge, it is recommended to note whether there is a vascular trauma when injecting the suspension vehicle, to immediately press hemostasis if it occurs, and to observe the local hemostatic effect in the treatment area.
In one embodiment, the injectable composite polymer suspension vehicle is in the form of a suspension medium in the subcutaneous fascia tissue of human skin.
In one embodiment, after the injection of the composite polymer degradable polymer suspension carrier is finished, the shaping is adjusted as required, the massage is finished until the massage is smooth, the needle hole is not sutured, and the erythromycin ointment is coated outside the needle hole, so that the postoperative swelling is reduced.
In conclusion, with the aid of the technical scheme, the invention provides a cosmetic injection method for wrinkle removal and collagen regeneration by hand injection, which is specifically injected into subcutaneous fascia tissue of the contour of depressed finger at the back of a hand by a skilled and safe injection of a medical practitioner by the principle of 5-dimensional point distance and V-point axis inclined edge, wherein each point is uniformly provided with a suspension carrier, by injecting a suspension liquid carrier, the suspension liquid carrier is injected into the subcutaneous fascia tissue through a needle to improve the skin relaxation and wrinkles, stimulate the proliferation of collagen fibers, fill and support the contour between the sunken fingers on the back of the hand, and can swell the skin of the contour between the sunken fingers on the back of the hand without more wound lacerations, thereby improving the loss of local collagen, not influencing the work and life of beauty lovers, and being characterized by quickly improving the hand collapse and the local skin aging.
In addition, the invention provides a solution that the deep maintenance and care of the contour skin between sunken fingers on the back of the hand are difficult to realize in the prior art. The technology proves that the beauty injection method for removing wrinkles by hand injection and regenerating collagen can achieve the lasting supporting effect of contour skin between sunken fingers on the back of a hand in a short period by injecting a suspension carrier by the principle of 5-dimensional point distance and V-point axis inclined edge, has the characteristics of stable physicochemical property, strong inertia and good biocompatibility, and has good effect after injection, and the technology proves that the hand fullness is effectively realized. Therefore, the invention provides a novel injection method for beautifying, which is matched with a composite high-molecular degradable polymer suspension carrier with good biocompatibility, is milder compared with other filling injection solutions, and the collagen hyperplasia of the hand contour skin can be maintained for about 1 year and half to 2 years, thereby having very important significance for injection beautifying.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (10)
1. A cosmetic injection method for wrinkle removal and collagen regeneration by hand injection is characterized by comprising the following steps:
s1, cleaning and disinfecting the back contour of the hand;
s2, preparing a composite high-molecular degradable polymer suspension carrier;
s3, injecting the beauty injection liquid into the axial line point of the oblique edge of the contour between the depressed fingers on the back of the hand;
s4, partitioning the hand back contour by using the principle of 5-dimensional point distance and position and V point axis inclined edge;
s5, injecting the composite high molecular degradable polymer suspension carrier to the partition axis point.
2. The cosmetic injection method for wrinkle removal and collagen regeneration by hand injection as claimed in claim 1, wherein said cleaning and disinfecting of the back contour of the hand comprises the following steps:
s101, cleaning the contour skin of the back of a hand by using clear water;
s102, after cleaning, performing sterile disinfection on the left and right sides of the back of the hand;
s103, sterilizing the injection part by 70 percent medical sterile alcohol solution before injection.
3. The cosmetic injection method for wrinkle removal and collagen regeneration by hand injection as claimed in claim 1, wherein said composite polymeric degradable polymer suspension carrier comprises polymeric tissue filler and synergist;
wherein the polymeric tissue filler comprises sodium hyaluronate and poly-L-lactic acid;
the synergist comprises sodium hydroxymethyl cellulose, mannitol, aloe polysaccharide, glycerol, amino acids, peptide, vitamins and growth factor.
4. The beauty injection method for wrinkle removal and collagen regeneration by hand injection as claimed in claim 3, wherein the preparation method for preparing the composite type high molecular degradable polymer suspension carrier comprises the steps of uniformly mixing the polymeric tissue filler and the synergist with the dispersion medium liquid, and compounding to obtain the composite type high molecular degradable polymer suspension carrier.
5. The beauty injection method for wrinkle removal and collagen regeneration by hand injection as claimed in claim 1, wherein said using 5-dimensional point distance, V-point axis oblique rim principle to partition the hand back contour comprises the following steps: the back contour of the hand is divided into a left-right symmetrical area A, an area B, an area C, an area D, an area E, an area F, an area G, an area H, an area I and an area J.
6. The method as claimed in claim 5, wherein injecting the composite polymer suspension carrier at the split-zone axial point comprises injecting the composite polymer suspension carrier at the point position of the depressed inter-digital contour of the back of the hand and at the oblique edge position of the depressed inter-digital contour of the back of the hand, respectively, using the principle of 5-dimensional point spacing and V-point axial oblique edge, and inserting the needle at an oblique angle of 10-15 degrees at the actual point position and oblique edge position of the back contour of the right hand and at the actual point position and oblique edge position of the depressed inter-digital contour of the back of the left hand, wherein the needle is blunt and the pushing needle is used for slow administration as appropriate.
7. The cosmetic injection method for wrinkle removal and collagen regeneration by hand injection as claimed in claim 6, wherein said injecting the composite polymer suspension carrier by injecting the composite polymer suspension carrier into the points of the contour between the depressed fingers on the back of the hand and the actual points of the contour on the back of the right hand with the gap of the bones of the fingers and inserting the needle head at an angle of 10-15 degrees obliquely according to the principle of 5-dimensional point spacing comprises the following steps:
s501, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area B in a preset direction;
s502, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area C in a preset direction;
s503, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area D in a preset direction;
s504, a needle inserting point is arranged at the position end along the area A, and 0.5ml of carrier is uniformly injected into the area E in a preset direction.
The method comprises the following steps of respectively injecting the composite high molecular degradable polymer suspension carrier into the dot orientation positions of the contour between the depressed fingers on the back of the hand by utilizing the principle of 5-dimensional dot distance positions, and completing the injection of the composite high molecular degradable polymer suspension carrier by inserting a needle head into the actual dot orientation positions of the contour between the depressed fingers on the back of the left hand in a manner of beveling by 10-15 angles by utilizing the gaps of the bones of the fingers:
s505, taking a needle inserting point at the position end along the F area, and uniformly injecting 0.5ml of carrier in the preset direction to the G area;
s506, a needle inserting point is arranged at the position end along the F area, and 0.5ml of carrier is uniformly injected into the H area in a preset direction;
s507, needle inserting points are arranged at the position end along the F area, and 0.5ml of carriers are uniformly injected into the I area in a preset direction;
s508, the needle inserting point is arranged at the position end along the F area, and 0.5ml of carrier is evenly injected to the J area in the preset direction.
8. The cosmetic injection method for wrinkle removal and collagen regeneration by hand injection as claimed in claim 6, wherein said injecting the composite polymer suspension carrier by injecting the composite polymer suspension carrier into the oblique rim of the contour between the depressed fingers on the back of the hand and inserting the needle at an angle of 10-15 degrees into the oblique rim of the contour on the back of the right hand by using the gap between the bones of the fingers by using the principle of the oblique rim of the V-point axis comprises the following steps:
s509, a needle inserting point is arranged at the position end along the B area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s510, a needle inserting point is arranged at the position end along the area B, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s511, a needle inserting point is arranged at the position end along the C area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s512, a needle inserting point is arranged at the position end along the area C, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s513, a needle inserting point is arranged at the position end along the D area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s514, a needle inserting point is arranged at the position end along the D area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s515, a needle point is arranged at the position end along the E area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s516, a needle inserting point is arranged at the position end along the E area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards.
The method comprises the following steps of respectively injecting a composite high molecular degradable polymer suspension carrier into the oblique edge position of the contour between the depressed fingers on the back of the hand by utilizing the principle of the oblique edge of the V-point shaft, and inserting a needle head into the oblique edge position of the contour on the back of the left hand at a beveling angle of 10-15 degrees by utilizing the clearance of the bones of the fingers to complete the injection of the composite high molecular degradable polymer suspension carrier:
s517, a needle inserting point is arranged at the position end along the G area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
s518, a needle inserting point is arranged at the position end along the G area, and 0.1ml-0.3ml of carrier is uniformly injected into the 2 points along the position end of the 2 points upwards;
s519, a needle inserting point is arranged at the position end along the H area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point upwards along the position end of the 1 point;
s520, a needle inserting point is arranged at the position end along the H area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s521, a needle inserting point is arranged at the position end along the area I, and 0.1ml-0.3ml of carrier is uniformly injected to the point 1 upwards along the position end of the point 1;
s522, a needle inserting point is arranged at the position end along the I area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards;
s523, a needle inserting point is arranged at the position end along the J area, and 0.1ml-0.3ml of carrier is uniformly injected to the 1 point along the position end of the 1 point upwards;
and S524, a needle inserting point is arranged at the position end along the J area, and 0.1ml-0.3ml of carrier is uniformly injected to the 2 points along the position end of the 2 points upwards.
9. The method as claimed in claim 6, wherein the injectable polymer suspension is in the form of suspension medium in the subcutaneous fascial tissue of human skin.
10. The beauty injection method for wrinkle removal and collagen regeneration by hand injection as claimed in claim 9, wherein the injection of the composite polymer suspension carrier is properly shaped and massaged smoothly, and the needle hole is not sutured and coated with erythromycin ointment to reduce postoperative swelling.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111238137.7A CN113855930A (en) | 2021-10-25 | 2021-10-25 | A skin caring injection method for removing wrinkle and regenerating collagen by hand injection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111238137.7A CN113855930A (en) | 2021-10-25 | 2021-10-25 | A skin caring injection method for removing wrinkle and regenerating collagen by hand injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113855930A true CN113855930A (en) | 2021-12-31 |
Family
ID=78997564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111238137.7A Pending CN113855930A (en) | 2021-10-25 | 2021-10-25 | A skin caring injection method for removing wrinkle and regenerating collagen by hand injection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113855930A (en) |
-
2021
- 2021-10-25 CN CN202111238137.7A patent/CN113855930A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11992580B2 (en) | Method of soft tissue augmentation | |
| Moscona et al. | Free-fat injections for the correction of hemifacial atrophy | |
| WO2008072229A2 (en) | Methods for dermal filling using microneedles | |
| US20140065221A1 (en) | Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material | |
| EP2606828B1 (en) | Hyaluronic acid and its use for treating venous insufficiency and varicose veins | |
| RU2135122C1 (en) | Method for producing skin rejuvenascence | |
| CN113855930A (en) | A skin caring injection method for removing wrinkle and regenerating collagen by hand injection | |
| CN219250552U (en) | Z-shaped barb shaping and beautifying lifting wire | |
| Bolivar de Souza Pinto | Importance of cervicomental complex treatment in rhytidoplasty | |
| RU2524610C1 (en) | Cosmetological set for lifting of soft tissues with use of meso-sutures and its application (versions) | |
| Jung et al. | A innovative form scaffold type of thread lift: its satisfactory performance and safety | |
| Van Loghem | Use of calcium hydroxylapatite for augmentation of the labia majora and mons pubis | |
| RU2186529C2 (en) | Method for correcting age alterations of facial and neck skin | |
| CN114404735A (en) | Beautifying injection method for eliminating neck wrinkles and beautifying injection for regenerating skin and assisting skin | |
| KR20180086054A (en) | Lifting Thread | |
| US20240041450A1 (en) | Ten-dimensional barbed surgical thread | |
| CN114432541A (en) | Cosmetic injection method adopting injection and lifting in front of ears | |
| RU2190376C1 (en) | Method for applying esthetic blepharoplasty | |
| CN114432544A (en) | Beauty injection method and skin regeneration beauty injection using multi-dimensional mesh line carving | |
| CN108079375B (en) | Built-in biological sleeve and preparation method and application thereof | |
| RU2186531C2 (en) | Method for removing facial and neck folds | |
| CN115364033A (en) | Technique for regenerating and repairing inner source of young face small needle | |
| CN114768001A (en) | Injection method for facial rejuvenation | |
| CN117942222A (en) | Method for retaining upper eyelid vascular network double eyelid forming | |
| CN114452485A (en) | Beauty injection method for pulling, lifting, tightening and shaping face on hairline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211231 |